Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.9M Sell
14,917
-717
-5% -$257K 0.32% 47
2025
Q4
$5.49M Sell
15,634
-551
-3% -$201K 0.33% 49
2025
Q3
$5.98M Sell
16,185
-113
-0.7% -$43.7K 0.37% 44
2025
Q2
$6.45M Buy
16,298
+3,683
+29% +$1.38M 0.43% 37
2025
Q1
$4.7M Sell
12,615
-20
-0.2% -$7.61K 0.36% 49
2024
Q4
$4.55M Sell
12,635
-26
-0.2% -$9.63K 0.36% 47
2024
Q3
$4.57M Buy
12,661
+484
+4% +$167K 0.38% 49
2024
Q2
$4.01M Sell
12,177
-761
-6% -$258K 0.36% 55
2024
Q1
$4.63M Buy
12,938
+157
+1% +$52.8K 0.48% 42
2023
Q4
$3.83M Sell
12,781
-71
-0.6% -$19.9K 0.46% 47
2023
Q3
$3.51M Sell
12,852
-243
-2% -$69.7K 0.48% 43
2023
Q2
$4M Sell
13,095
-1,071
-8% -$309K 0.53% 36
2023
Q1
$4.04M Sell
14,166
-3,252
-19% -$863K 0.58% 36
2022
Q4
$4.26M Sell
17,418
-394
-2% -$89.4K 0.67% 27
2022
Q3
$3.61M Buy
17,812
+192
+1% +$40.4K 0.62% 32
2022
Q2
$3.86M Buy
17,620
+2,534
+17% +$595K 0.6% 40
2022
Q1
$4.03M Buy
15,086
+762
+5% +$197K 0.6% 43
2021
Q4
$3.83M Buy
14,324
+708
+5% +$186K 0.43% 49
2021
Q3
$3.59M Buy
13,616
+693
+5% +$185K 0.46% 46
2021
Q2
$3.36M Buy
12,923
+1,528
+13% +$391K 0.37% 57
2021
Q1
$2.78M Buy
11,395
+398
+4% +$95.4K 0.27% 68
2020
Q4
$2.69M Buy
10,997
+1,495
+16% +$339K 0.24% 74
2020
Q3
$1.98M Buy
9,502
+1,800
+23% +$350K 0.18% 82
2020
Q2
$1.39M Buy
7,702
+637
+9% +$118K 0.14% 82
2020
Q1
$1.18M Buy
7,065
+368
+5% +$71.9K 0.15% 75
2019
Q4
$1.41M Buy
6,697
+1,150
+21% +$239K 0.15% 72
2019
Q3
$1.2M Buy
5,547
+250
+5% +$53.6K 0.15% 71
2019
Q2
$1.09M Buy
5,297
+550
+12% +$105K 0.12% 73
2019
Q1
$938K Buy
4,747
+1,003
+27% +$181K 0.11% 76
2018
Q4
$587K Buy
3,744
+2,457
+191% +$411K 0.08% 106
2018
Q3
$229K Buy
+1,287
New +$220K 0.03% 169

Other funds holding SYK

Keel Point's SYK Position: Q1 2026 in Review

Keel Point reduced its Stryker (SYK) stake by 4.6% in Q1 2026, selling an estimated $257K and leaving 14,917 shares worth $4.9M. The position accounts for 0.32% of the portfolio, ranked #47.

Keel Point first reported a position in SYK in Q3 2018 and has held it in 31 quarters since. The position peaked at $6.45M in Q2 2025. 2,293 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Keel Point held 14,917 shares of Stryker worth $4.9M as of Q1 2026.
  • Keel Point sold 717 Stryker shares in Q1 2026, an estimated $257K.
  • Stryker made up 0.32% of Keel Point's portfolio in Q1 2026, its #47 holding.
  • Keel Point first reported a position in Stryker in Q3 2018 and has held it in 31 quarters since.
  • Keel Point's Stryker position peaked at $6.45M in Q2 2025.
  • 2,293 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.